Français

Contact us in Quebec


Here in Quebec, we are home to a strong community of volunteers, donors and sponsors, as well as an innovative team of researchers and health professionals. These people are the heart and soul of our organization, and there are so many exciting ways to get involved! Every volunteer, donor, researcher and sponsor helps us to improve the lives of those affected by Crohn’s disease and ulcerative colitis, and brings us closer to finding cures.

For general and in-memory donations, please call 514-342-0666 ext. 201
For French inquiries, please call 514-342-0666 ext. 202

Director, Major Gifts and Corporate Engagement, Quebec
Katherine Digby


Development and Community Engagement, Montréal
Konstantine Malakos

514-968-2079

Events

Family sitting on the floor of their living room playing

Caregiver Peer Connect Event

Ready to connect with those who understand the challenges of Crohn’s disease, ulcerative colitis, and other forms of inflammatory bowel disease (IBD)?  Join our upcoming Peer Connect ...

 • 
Virtual
 • 
Speaker giving a presentation

Pain in Crohn's and Colitis

DetailsDate: December 5, 2024 Time: 7:00 - 8:30 p.m. ETAre you or a loved one struggling with pain when living with Crohn's disease or ulcerative colitis? Have you ever wondered why some pain ...

 • 
ZOOM (Virtuel)
 • 
Group of friends who are older adults chatting with each other

Canada Wide Peer Connect Event

Ready to connect with those who understand the challenges of Crohn’s disease, ulcerative colitis, and other forms of inflammatory bowel disease (IBD)?  Join our upcoming Peer Connect event ...

 • 
Virtual
 • 
Remember to bookmark this page.

PROVINCE OF QUEBEC’S OFFICE

5530 Rue Ferrier
Mont-Royal, QC H4P 1M2

kdigby@crohnsandcolitis.ca 514-342-0666 ext. 201 1-800-461-4683 (Québec and NB only)

Search by Postal Code

News

“You don’t need to be superhuman”: How a small-town hockey player made it to the NCAA in the face of Crohn’s disease

“You don’t need to be superhuman”: How a small-town hockey player made it to the NCAA in the face of Crohn’s disease

Takeda Canada announces positive results for ENTYVIO® (vedolizumab) vs. Humira® (adalimumab) in first IBD study to compare biological agents head-to-head

Takeda Canada announces positive results for ENTYVIO® (vedolizumab) vs. Humira® (adalimumab) in first IBD study to compare biological agents head-to-head

 39 40 41 42 43 44 45 46 47 48